Drug Profile


Alternative Names: NSC 336628

Latest Information Update: 11 Sep 1996

Price : $50

At a glance

  • Originator Uniroyal Chemical
  • Class Barbiturates; Small molecules
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 11 Sep 1996 Discontinued-II for Cancer in USA (IV)
  • 11 Sep 1996 Discontinued-Preclinical for Cancer in Canada (Unknown route)
  • 08 Mar 1996 A study has been added to the Cancer therapeutic trials and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top